FFP-104

• Description :

  FFP-104 is a humanized IgG4 monoclonal antibody inhibitor targeting TNFRSF5/CD40. VX70 can be used for chronic autoimmune liver diseases research, such as primary biliary cholangitis (PBC) [1].

• UNSPSC :

  12352203

• Target :

  TNF Receptor

• Related Pathways :

  Apoptosis

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• References & Citations :

  [1]Khanna A, et al. Novel strategies and therapeutic options for the management of primary biliary cholangitis[J]. Therapeutic Advances in Gastroenterology, 2017, 10 (10) : 791-803.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• Isoform :

  TNFRSF5/CD40

• CAS Number :

  [2378693-56-0]